The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT)

Abstract

Cyclophosphamide (CY) cardiotoxicity induces a rare lethal complication associated with its use. The minimum dose for cardiac toxicity is still not known, although there are no reports of CY toxicity at doses of less than 100 mg/kg. There are few studies of CY cardiotoxicity that included a large number of patients who received high-dose CY for conditioning… (More)
DOI: 10.1007/s00277-016-2654-6

Topics

2 Figures and Tables

Cite this paper

@article{Ishida2016TheCF, title={The clinical features of fatal cyclophosphamide-induced cardiotoxicity in a conditioning regimen for allogeneic hematopoietic stem cell transplantation (allo-HSCT)}, author={Shinya Ishida and Noriko Doki and Naoki Shingai and Kosuke Yoshioka and Kazuhiko Kakihana and Hisashi Sakamaki and Kazuteru Ohashi}, journal={Annals of Hematology}, year={2016}, volume={95}, pages={1145-1150} }